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Introduction: Pupillometers objectively measure constriction (i.e., parasympathetic pathway) 
and dilation (i.e., sympathetic pathway) velocities of the pupillary reflex. These pathways may 
be affected by increases in ventricular size due to changes in cerebrospinal fluid (CSF) volume, 
such as during external ventricular device (EVD) weaning in aneurysmal subarachnoid 
hemorrhage (aSAH) patients. This pilot study evaluated if changes in pupillary responses could 
be predictive of EVD weaning failure in aSAH patients. Additionally, we analyzed ventricular 
size and pupillary reactions in these two groups.  
Methods: Adult aSAH patients serially monitored with the pupillometer at an academic medical 
center were included. Patients were grouped into those successfully weaned from the EVD and 
those who were not. Pupillometer measurements (e.g. changes in constriction and dilation 
velocities), changes in intracranial pressure (ICP), changes in cerebral aqueduct diameter and 3
rd
 
ventricle diameter (measured via computed tomography head (CTH)) were evaluated between 
the two groups.  
Results: Seven patients met the inclusion criteria. Three patients required ventriculoperitoneal 
shunting. There were no significant differences in the changes in constriction or dilation 
velocities between the groups. Additionally, there was no significant difference in ICP. There 
were significant differences between the changes in size of the cerebral aqueduct (p=0.01) and of 
the third ventricle (p=0.01) on CTH between those who weaned and those who did not. These 
did not correlate with pupillometer measurements. 
Conclusions: We did not find predictive value in changes in constriction or dilation velocities or 
ICP on EVD weaning success in aSAH patients. Changes in the diameter of the third ventricle or 
cerebral aqueduct may be predictive of EVD weaning and suggests a further avenue for study. 
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INTRODUCTION 
 
Change in pupillary size is a commonly used 
prognostic indicator facilitating early 
recognition of a worsening neurologic 
condition, e.g. herniation. The fact that an 
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abnormal result in pupillary assessment (e.g. 
non-reactivity and/or mydriasis) triggers a 
cascade of diagnostic and therapeutic 
procedures underscores its importance.
1
 
While early, accurate, and reliable detection 
of pupillary changes is important, the 
problem of interobserver variability and 
varying evaluative schemas associated with 
manual pupillary observation are well 
known.
2,3
 Recent studies continue to confirm 
inadequate levels of practitioner agreement 
in regards to pupillary reactivity when 
traditional, manual pupillary assessments for 
patients with neurologic injury are used.
2,3 
Pupillometers may represent the next step in 
the evolution of neurocritical care because 
they are automated, computer-based, and 
use infrared digital video technology to 
objectively measure pupillary size and 
reactivity.
4
 Pupillometers may have a role as 
a prognostic indicator of developing 
hydrocephalus which may occur in the 
weaning of external ventricular devices 
(EVD) in patients with aneurysmal 
subarachnoid hemorrhage (aSAH). 
The etiology of hydrocephalus in 
patients suffering aSAH is either due to an 
obstruction in the ventricular system or 
decreased cerebrospinal fluid (CSF) 
absorption from fibrosis of the 
leptomeninges and arachnoid granulations 
caused by inflammation and deposition of 
blood products.
5 
Regardless of etiology, CSF 
diversion is typically indicated in these 
patients. This is routinely accomplished via 
temporary EVD placement, with the hope of 
successful weaning and removal. 
6
 Patients 
who fail the weaning process are considered 
to have developed chronic hydrocephalus 
and require permanent shunting.
7
 The 
purpose of our pilot study is to use 
pupillometers to evaluate subtle pupillary 
reactivity changes in patients with 
developing hydrocephalus secondary to 
aSAH. The goal is to identify a noninvasive 
prognostic marker that will aid in EVD 
weaning.   
 
METHODS 
Patients 
We retrospectively reviewed prospectively 
collected data over a six-month period of 
adult patients (>18 years of age) admitted 
with aSAH to the neurosciences intensive 
care unit (NSICU) at a tertiary, academic 
medical center. The Institutional Review 
Board approved this study.  
 The collected demographic data 
included age, sex, reason for admission, 
surgical intervention, Glasgow Coma Score 
(GCS), Hunt and Hess score, Fisher Grade 
score, temperature (Celsius), and serum 
sodium level. Additionally, EVD settings, 
cerebrospinal fluid (CSF) drainage over 
prior 24 hours, intracranial pressure (ICP) 
data, and computed tomography (CT) 
imaging data were also acquired.  
 Patients were excluded if 
pupillometer data was collected on 
intravenous sedation (e.g. propofol, 
dexmedetomidine) and/or analgesia (e.g. 
fentanyl). Figure 1 illustrates inclusion/ 
exclusion of patients. 
 
 
Figure 1: Patient Inclusion / Exclusion Flowchart.  
 
Pupillometer 
The NeurOptics pupillometer (NeurOptics, 
Irvine, CA, USA) was used in this study to 
evaluate pupillary physiology. In our 
NSICU, pupillometer assessments were 
collected by procedural protocol. A 
pupillometer headrest, specific to each 
patient, was attached to the pupillometer.  
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Table 1. Definitions of Pupillometer Variables 
 
Prior to pupil assessment, all room lights 
were off, blinds were down, and hall curtain 
drawn closed. The pupillometer was 
powered on. The eye was scanned by 
positioning the headrest with the lower pad 
below the eye and holding the eyelid open. 
The eye was then scanned. The right eye 
(OD) was scanned first followed by the left 
eye (OS). 
 Pupillometer data collected from 
each eye included Neurological Pupillary 
Index (NPi), baseline size, minimum size 
after bright light, constriction velocity (CV), 
maximum constriction velocity (MCV), 
latency, and dilation velocity (DV). These 
variables have been previously explained 
and are summarized in Table 1.
1
  
 
Neuroimaging 
Axial CT head images were obtained on a 
64-multislice scanner (General Electrics 
Healthcare, Chicago, IL). These were 
blindly reviewed by one of the authors 
(CRN). The diameter measurements of the 
ventricular system were obtained, including 
the cerebral aqueduct in the midbrain at the 
level of the superior colliculus and the third 
ventricle at the level of the hypothalamus. 
Figure 2 is an illustrative example.   
 
Statistics 
Continuous and categorical data were 
summarized with descriptive statistics 
including means and standard deviations 
(continuous data) and frequencies 
(categorical data). Average ICP values were 
calculated using data collected from 9AM to 
12PM, the cluster of hours surrounding the 
pupillometer data collection. Pupillometer 
data was collected daily at 9AM, a time 
chosen to facilitate identification of transient 
changes in pupillary function because it 
follows changes made in EVD settings by 
the rounding neurosurgical team. Velocity 
measurements were compared to ICP and 
changes in ventricular diameter on axial 
computed topography (CT) scans of the 
head at the level of the third ventricle and at 
the cerebral aqueduct using Pearson 
Correlation. Student t-test was used to 
compare the continuous demographic data 
as well as CV and DV between those who 
pass EVD weaning from those who fail 
EVD weaning. If patients developed delayed 
hydrocephalus and required a ventriculo-
peritoneal shunt, these patient(s) were 
included in the EVD weaning failure group 
for statistical analyses. A p value of <0.05 
was considered significant. Data were 
analyzed using GraphPad Prism 7 (La Jolla, 
CA, USA). 
Variable Definition
Npi (neurological 
pupil index)
Composite pupillary response number based on an algorithm using 
physiological pupil variables and comparing them to a normative model.
Latency (s)
The time difference between light stimulation and the onset of pupillary 
constriction.
Constriction 
velocity (mm/s)
An average velocity calculated by the pupil constriction divided by the duration 
of the constriction.
Maximum 
constriction 
velocity (mm/s)
Peak constriction velocity.
Dilation velocity 
(mm/s)
An average velocity calculated by pupil dilation divided by the duration of the 
dilation.
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Figure 2. Computed Tomography (CT) Head. CT head showing the third ventricle prior to (A) and 24 hours after 
(B) external ventricular (EVD) clamping. There is marked enlargement of the third ventricle. CT head at the level of 
the cerebral aqueduct prior to (C) and 24 hours after (D) EVD clamping. The cerebral aqueduct had significant 
increase in diameter.  
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Table 2. Patient Demographics. 
 
Abbreviations; yrs, years; SD, standard deviation; 
o
C, degrees Celsius; ICP, intracranial pressure; n, number; EVD, 
external ventricular device; NS, nonsignificant 
 
RESULTS 
 
The mean age was 57.6 (±14) years, with a 
range of 35 to 76 years. Seven aSAH 
patients (3 males; 4 females) met the 
inclusion criteria. The average Hunt and 
Hess and Fisher Grade scores for all patients 
were 2.43 (±1.13) and 3.43 (+ 0.54), 
respectively. These clinical variables did not 
change significantly comparing those who 
passed EVD weaning to those who failed. 
Additionally, serum sodium, temperature, 
and ICP did not change significantly in 
those who passed EVD weaning compared 
to those who failed EVD weaning. Table 2 
summarizes the patient demographics.  
Two patients immediately failed 
weaning and required ventriculoperitoneal 
(VP) shunting. One patient initially passed 
the weaning process, only to develop 
delayed hydrocephalus requiring VP 
shunting two-weeks later. Four patients did 
not develop hydrocephalus during EVD 
weaning. The average pupil sizes were 3.22 
(±1.20) mm OD and 3.25 (±1.02) mm OS 
(p=0.97) among all patients. Those who 
passed EVD weaning showed average pupil 
sizes of 3.01 mm (±1.17) OD and 3.27 
(±1.09) mm OS (p=0.76), and those who 
failed were 3.51 (±1.44) mm OD and 3.22 
(±1.12) mm OS (p=0.79). The average 
change in OD CV among those passing 
weaning was 1.39 (±1.44) m/s, and in those 
who failed, it was 0.06 (±0.23) m/s (p = 
0.18). The average change in OS CV 
between those who passed and failed 
weaning was 0.92 (±1.98) m/s and 0.43 
(±0.29) m/s (p = 0.70), respectively. 
Comparison of the OD and OS change in 
DV among both groups also showed no 
significant difference (p = 0.16 and p = 0.65, 
respectively). Overall, there were no 
statistically significant differences in the 
pupillary function to distinguish those who 
passed EVD weaning from those who failed. 
Table 3 summarizes the pupillometer data.  
The changes in the diameter of the 
cerebral aqueduct and 3
rd
 ventricle measured 
on axial CT heads of patients showed 
significance between patients who passed 
versus those who failed EVD weaning. The 
average change in 3
rd
 ventricle diameters 
were 0.04 (±0.03) cm and 0.93 (±0.40) cm 
(p = 0.01), respectively. Likewise, the 
average changes in aqueduct diameter were 
0.07 (±0.05) cm in those who passed versus 
0.46 (±0.21) cm in those who failed 
(p=0.01).  
 
DISCUSSION 
 
Changes in the CSF volume are well-known 
occurrences during EVD weaning in patients 
with aSAH. While hydrocephalus may be 
treated in the acute phase with EVD 
placement, markers enabling clinicians to 
identify patients requiring long-term CSF 
diversion are highly desirable. Our pilot 
study failed to show a pupillometer-based 
marker to reliably identify patients who  
Total
(n = 7) (n = 4) (n = 3) p value
Age (yrs; mean, SD) 58 (±14) 60 (±18) 55 (±10) NS
Sex (Male, %) 4 (57.1%) 2 (28.6%) 2 (28.6%) NS
Hunt and Hess Score (mean, SD) 2.43 (±1.13) 2 (±0) 3 (±1.73) NS
Fisher Grade Score (mean, SD) 3.43 (±0.54) 3.25 (±0.5) 3.67 (±0.57) NS
Temperature (º C; mean, SD) 36.8 (±0.99) 36.7 (±0.88) 37.0 (±1.31) NS
Sodium (mean, SD) 142.4 (±2.30) 142.8 (±1.26) 142.0 (±3.61) NS
ICP (mmHg; mean, SD) 8.16 (±2.86) 7.67  (±2.76) 8.81 (±3.46) NS
Passed EVD weaning Failed EVD weaning
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Table 3. Patients Pupil Physiological Variables. 
 
Abbreviations: OD, right eye; OS, left eye; SD, standard deviation; ICP, intracranial pressure; CV, constriction 
velocity; DV, dilation velocity; NPi, neurological pupillary index 
 
would fail or pass CSF diversion weaning. 
However, significant changes observed in 
the diameters of the cerebral aqueduct and 
3
rd
 ventricle measured via CT head were 
promising and represent a possible avenue 
of future study.  
Changes in the pupil size are a well-
known clinical finding used to identify 
intracranial changes. For example, 
compression of the posterior communicating 
(PCOM) and posterior cerebral (PCA) 
arteries by an aneurysm is a well-
documented cause of oculomotor palsy with 
pupillary dilation.
8
 Other causes of 
oculomotor nerve dysfunction resulting in 
concomitant pupillary changes are central 
nervous system tumors, midbrain infarction, 
trauma, and cavernous sinus lesions.
9
 
Among the classically known signs are 
small but reactive pupils found with injury 
to pupillodilator (i.e., sympathetic) fibers at 
the level of the hypothalamus and the 
pinpoint pupils associated with injury to the 
pontine region.
10 
Likewise, an injury to both 
parasympathetic and sympathetic fibers 
results in midposition, fixed pupils similar to 
that associated with brain death.
11
 Since the 
pupillometer enables rapid, easy 
measurement of CV (i.e., parasympathetic 
function) and DV (i.e., sympathetic 
function), evaluating these measurements in 
aSAH patients during the EVD weaning 
period may be a marker for EVD weaning 
success.  
The pupilloconstrictor fibers (i.e., 
parasympathetic nervous system) originate 
in the Edinger-Westphal nuclei of the rostral 
midbrain at the level of the superior 
colliculus within paired nuclei located 
posteriorly to the oculomotor nucleus and 
anterolaterally to the cerebral aqueduct.
8
 
These fibers course along the peripheral 
aspect of the oculomotor nerve bundle as it 
exits the midbrain.
8
 They then transit the 
interpeduncular cistern, course within the 
wall of the cavernous sinus, and finally 
pierce the dura to exit the cranium via the 
superior orbital fissure.
8 
This course 
suggests obvious vectors for impingement 
resulting in pupillary abnormality. Similarly, 
the pupillodilator fibers (i.e., sympathetic 
nervous system) originate in the 
paraventricular nucleus within the 
hypothalamus.
8 
They then descend 
uncrossed through the posterolateral 
tegmentum of the midbrain, pons, and 
medulla into the cervical spinal cord, 
synapsing at the lateral horn neurons of C8, 
T1, and T2 segments.
8,12
 Preganglionic 
fibers then leave the cord (primarily at the 
T2 ventral root), traverse the stellate 
ganglion and then synapse in the superior 
cervical ganglion. Finally, postganglionic 
fibers form the carotid plexus, enter the  
 
p value
Change in OD NPI (+ SD) -0.13 ± 0.62 -0.03 ± 0.68 0.85
Change in OS NPI (+ SD) -0.28 ± 0.69 0.27 ± 0.35 0.27
Change in OD CV (+ SD) 1.39 ± 1.44 0.06 ± 0.23 0.18
Change in OS CV (+ SD) 0.92 ± 1.98 0.43 ± 0.29 0.70
Change in OD DV (+ SD) 0.59 ± 0.63 -0.04 ± 0.18 0.16
Change in OS DV (+ SD) 0.53 ± 0.90 0.26 ± 0.33 0.65
Change in ICP (+ SD) 1.58 ± 1.28 2.61 ± 4.08 0.65
Change in 3rd Ventricle (+ SD) 0.04 ± 0.03 0.93 ± 0.40 0.01
Change in aqueduct  (+ SD) 0.07 ± 0.05 0.46 ± 0.21 0.01
Passed Failed
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Figure 3. Cartoon of Cerebrospinal Fluid (CSF) and Proximity to Parasympathetic and Sympathetic Nervous 
Systems. The pupilloconstrictor fibers (i.e., parasympathetic nervous system) originate in the Edinger-Westphal 
nuclei of the rostral midbrain. These fibers are anterolateral to the cerebral aqueduct and transit the interpeduncular 
cistern. The pupillodilator fibers (i.e., sympathetic nervous system) originate in the paraventricular nucleus of the 
hypothalamus. These fibers could be affected by CSF volume at the level of the third ventricle, which is in close 
proximity to the paraventricular nucleus, and in the posterolateral tegmentum, which is close to the fourth ventricle.  
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cranial cavity, traverse the cavernous sinus, 
join the ophthalmic artery, and reach the eye 
as the long ciliary nerve innervating the 
dilator muscle of the iris.
8,13
 The proximity 
of the paraventricular nucleus to the third 
ventricle and the course of the pupillodilator 
fibers present several locations for changes 
in CSF volume and ventriculomegaly to 
influence CV and DV. These sites include 
compression at the paraventricular nuclei, 
the posterolateral tegmentum close to the 
fourth ventricle, at the exit point of the 
spinal cord, within the wall of the cavernous 
sinus, and within the long ciliary nerve as it 
pierces the dura to exit the cranium and 
enter the orbit.  
Figure 3 is a cartoon illustrating 
potential sites for CSF volume changes to 
influence CV and DV. We hypothesize that 
local changes at the level of the 3
rd
 ventricle 
and/ or cerebral aqueduct could cause 
changes in the pupillary physiology in those 
who fail EVD weaning. Indeed, we found 
that changes at these levels on head CT do 
predict EVD weaning and failure. However, 
pupillary function was not found to be 
significantly affected by changes in CSF 
volume.   
Because pupillary function can 
reflect intracranial changes, reliable methods 
of measurement are needed. In the setting of 
evaluation and management of brain injury, 
this need is great considering the 
vulnerability of pupillary measurements due 
to variations related to the examiner (e.g. 
experience level and visual acuity) and 
factors commonly found in the NSICU 
setting (e.g. variations in ambient lighting 
and equipment).
2,3
 One study, while 
reporting high inter-rater reliability among 
nurses measuring pupillary size, reported 
low agreement when assessing pupillary 
reactivity.
14
 A more recent study showed 
that different levels of staff (e.g. ambulance 
vs. hospital) recorded significant differences 
in pupil sizes.
15
 Yet another study found 
senior neurology residents to have moderate 
inter-rater reliability for pupil size 
assessment and low agreement in 
discovering anisocoria.
16
 By contrast, the 
pupillometer is an objective, consistent 
method of evaluating pupillary function.
1
 It 
is important to note patients may have pre-
existing ocular, systemic, or neurological 
disease.
1
 Since the pupillometer is 
noninvasive and theoretically immune to 
inter-rater variability when used in a 
controlled manner, its use in identifying 
prognostic markers during EVD weaning is 
ideal. 
Our data suggests that ICP was not 
an accurate predictor of EVD failure or 
variation in pupillometer-measured CV and 
DV values. In our study, the average ICP 
was 8.81 (± 3.46) mmHg in those who failed 
EVD weaning. It has been shown that 
measured ICP does not always correspond to 
the pressure being withstood by nerve fibers 
in various locations of the central nervous 
system (CNS). For example, CSF pressure 
in the optic nerve subarachnoid space and 
lumbar cistern is now known to be 
somewhat less than that of the intracranial 
space.
17
 This finding is likely due to the 
buffering capacity of the CSF-filled 
ventricular system.  
We excluded patients who were on 
continuous sedation and/ or analgesia since 
pupil size and function can be affected by 
these medications.
18,19
 One recent study 
established that fentanyl decreased pupil 
size and altered pupil light reactivity but did 
not change the NPi.
18
 Another study 
observed transient, symmetrical CV 
reductions in an outpatient population after 
administration of narcotics (oral or IV) and 
benzodiazepines.
20
 For these reasons, we 
excluded patients who were on continuous 
sedation/analgesia infusion. 
This was a retrospective study with 
strict inclusion criteria. It was limited by the 
low number of patients. Because of the 
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sample size, it is difficult to generalize to the 
population. However, no trend was observed 
in the patients we evaluated. Additionally, 
inter-rater reliability of the ventricular sizes 
was not calculated. Given the significance of 
ventricular size and weaning future studies 
should evaluate this as a marker for EVD 
weaning.   
In conclusion, our data suggest that 
pupillary physiological variables were not 
reliable in differentiating which aSAH 
patients will pass and which will fail EVD 
weaning.  
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